Neonatal bacterial meningitis continues to be an important cause of mortality and morbidity. Contributing factors to such mortality and morbidity include our incomplete knowledge on the pathogenesis of how meningitis-causing bacteria penetrate the blood brain barrier, emergence of antimicrobial resistance, and difficulty in early diagnosis of meningitis. An early empiric antibiotic treatment is critical for the management of neonates with bacterial meningitis, but early recognition of neonatal meningitis continues to be a challenge. Bacterial nucleic acid–based detection of pathogens and cerebrospinal fluid biomarkers will help in the development of early diagnosis of neonatal bacterial meningitis. Bacterial penetration of the blood brain barrier is essential for the development of meningitis, and the continued elucidation of microbial penetration of the blood brain barrier is likely to bring a new approach for prevention and therapy of neonatal bacterial meningitis.
Skip Nav Destination
Article navigation
September 2015
Article|
September 01 2015
Neonatal Bacterial Meningitis
Kwang Sik Kim, MD
Kwang Sik Kim, MD
*Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
Search for other works by this author on:
Author Disclosure
Dr Kim has disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
Neoreviews (2015) 16 (9): e535–e543.
Citation
Kwang Sik Kim; Neonatal Bacterial Meningitis. Neoreviews September 2015; 16 (9): e535–e543. https://doi.org/10.1542/neo.16-9-e535
Download citation file:
Sign in
Don't already have an account? Register
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Pay-Per-View Access
$35.00
Comments